Ahrens Investment Partners LLC Moderna, Inc. Transaction History
Ahrens Investment Partners LLC
- $200 Million
- Q1 2023
A detailed history of Ahrens Investment Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 30 shares of MRNA stock, worth $956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$956% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
903Shares Held
234MCall Options Held
10.6MPut Options Held
18.5M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.29 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.24 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$815 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$537 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$230 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...